Control Bionics Limited (CBL.XA)

0,0510 -0,0020 (-3,77%) Alla chiusura: 10:42AM AEST

Control Bionics Limited

697 Bourke Road
Level 5, Suite 5.01
Camberwell, VIC 3124
Australia
61 3 9897 3576
https://www.controlbionics.com

Settore/i: 
Settore: 
Impiegati a tempo pieno: 

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Jeremy E. Steele	CEO, MD & Director	363,72k	N/D	N/D
Mr. Peter Shann Ford	Founder & Non-Executive Director	215,75k	N/D	N/D
Mr. Dominik Kucera	Interim Chief Financial Officer	373,96k	N/D	N/D
Mr. James Schorey	Chief Technology Officer	N/D	N/D	N/D
Ms. Meagan Koeneman	Sales Director	N/D	N/D	N/D
Mr. Brett Thomas Crowley B.Com., BCom, C.A., CA, DipLaw	Company Secretary	N/D	N/D	1957

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in AUD.

Descrizione

Control Bionics Limited, together with its subsidiaries, engages in the research, development, commercialization, and sale of assistive communications technology systems in Australia and North America. The company offers NeuroNode Trilogy and NeuroNode3 systems that allow people with speech and movement difficulties to control a computer for speech generation, electronic communications, entertainment, and external control of other devices. It also provides Cosmos Connect, a small portable control device that can be used with a Windows display device; NeuroNode, a wireless wearable sensor that gives the user the ability to access their technology by bioelectric signals or spatial movements; Uno Touch, a speech generating device; NeuroNode Duo, a wireless sensor; and Eye gaze Duo that allows the user to control a computer mouse with their eyes. The company was formerly known as Control Bionics Holdings Pty Limited and changed its name to Control Bionics Limited in September 2020. Control Bionics Limited was incorporated in 2005 and is based in Camberwell, Australia.

Governance aziendale

L'ISS Governance QualityScore di Control Bionics Limited al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.